Type to search

FDA Granted Orphan Drug Designation to CER-001 for the Treatment of LCAT Deficiency | Pharmtech Focus
ABIONYX Announces New Positive Clinical Results for CER-001 in Kidney Disease Associated with LCAT Deficiency Published in The Journal of Internal Medicine | Pharmtech Focus